
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
- Analyst Ratings
Upturn AI SWOT
- About


Streamline Health Solutions Inc (STRM)



- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)


(see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
04/01/2025: STRM (1-star) is currently NOT-A-BUY. Pass it for now.
Analysis of Past Performance
Type Stock | Historic Profit -78.7% | Avg. Invested days 28 | Today’s Advisory PASS |
Upturn Star Rating ![]() ![]() | Upturn Advisory Performance ![]() | Stock Returns Performance ![]() |
![]() ![]() | ![]() ![]() |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 15.34M USD | Price to earnings Ratio - | 1Y Target Price 22.5 |
Price to earnings Ratio - | 1Y Target Price 22.5 | ||
Volume (30-day avg) 8573 | Beta 1.64 | 52 Weeks Range 1.85 - 9.75 | Updated Date 03/30/2025 |
52 Weeks Range 1.85 - 9.75 | Updated Date 03/30/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -2.35 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -92.72% | Operating Margin (TTM) -71.44% |
Management Effectiveness
Return on Assets (TTM) -10.54% | Return on Equity (TTM) -80.09% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 23127617 | Price to Sales(TTM) 0.63 |
Enterprise Value 23127617 | Price to Sales(TTM) 0.63 | ||
Enterprise Value to Revenue 1.24 | Enterprise Value to EBITDA -24.03 | Shares Outstanding 4273180 | Shares Floating 25943347 |
Shares Outstanding 4273180 | Shares Floating 25943347 | ||
Percent Insiders 24.22 | Percent Institutions 20.37 |
Analyst Ratings
Rating 5 | Target Price 22.5 | Buy - | Strong Buy 1 |
Buy - | Strong Buy 1 | ||
Hold - | Sell - | Strong Sell - | |
Strong Sell - |
Upturn AI SWOT
Streamline Health Solutions Inc

Company Overview
History and Background
Streamline Health Solutions, Inc. was founded in 1989. It provides revenue cycle management and data analytics solutions for healthcare organizations. The company has evolved from a focus on document management to a broader range of revenue integrity solutions.
Core Business Areas
- eValuator: Pre-bill revenue integrity program that identifies coding errors and reimbursement opportunities before claims are submitted.
- RevID: Automated system for auditing and recovering lost revenue. Focuses on post-bill review.
- Looking Glass: Analytics platform providing insights into revenue cycle performance, identifying trends and areas for improvement.
Leadership and Structure
Tee Green is the President and CEO. The company has a typical corporate structure with departments for sales, marketing, finance, technology, and operations.
Top Products and Market Share
Key Offerings
- eValuator: A pre-bill revenue integrity solution. Market share data is not readily available. Competitors include companies offering similar pre-bill auditing and coding accuracy solutions. It's tough to get exact market share numbers in this niche market, but some main competitors include Optum, 3M, and nThrive. Revenue is not made public by product
- RevID: An automated post-bill revenue recovery solution. Market share data is not readily available. Competitors in this area include companies specializing in claims auditing and revenue recovery. Competitors include companies such as Change Healthcare and Conduent. Revenue is not made public by product
- Looking Glass: A business intelligence and analytics platform tailored for healthcare revenue cycle management. Market share data is difficult to pinpoint due to the diverse landscape of healthcare analytics vendors. Competitors include Tableau and Microsoft Power BI, but these are general BI tools. Revenue is not made public by product
Market Dynamics
Industry Overview
The healthcare revenue cycle management market is growing, driven by increasing regulatory complexity, the shift to value-based care, and the need for hospitals and health systems to optimize their revenue streams.
Positioning
Streamline Health Solutions positions itself as a provider of revenue integrity solutions that help healthcare organizations improve financial performance by identifying and preventing revenue leakage. Focuses on the pre-bill which gives them an advantage.
Total Addressable Market (TAM)
The healthcare revenue cycle management market is estimated to be worth billions of dollars. Streamline Health Solutions' TAM is a portion of this, focused on revenue integrity solutions. Size estimates range from $80 Billion to 100 Billion. Their position in pre-bill integrity gives them a leading edge but they need to scale up quickly.
Upturn SWOT Analysis
Strengths
- Specialized expertise in healthcare revenue cycle management.
- Solutions focused on pre-bill revenue integrity (eValuator).
- Strong client relationships in some segments.
- Proprietary technology platform (Looking Glass).
Weaknesses
- Smaller size compared to larger competitors.
- Limited market share in certain segments.
- Financial performance variability.
- Dependence on key personnel.
Opportunities
- Increasing demand for revenue cycle optimization solutions.
- Expansion into new healthcare verticals.
- Partnerships with other healthcare IT vendors.
- Adoption of AI and machine learning in revenue cycle management.
Threats
- Intense competition from larger, well-established players.
- Changing regulatory landscape.
- Economic downturn impacting healthcare spending.
- Technological disruptions in healthcare IT.
Competitors and Market Share
Key Competitors
- OTEX
- CPSI
- ALLS
Competitive Landscape
Streamline Health Solutions faces intense competition in the healthcare revenue cycle management market. Larger companies have more resources and established customer bases. Streamline differentiates through its focus on pre-bill solutions but must continue to innovate to maintain its competitive edge. They need to gain more market share quickly.
Major Acquisitions
Growth Trajectory and Initiatives
Historical Growth: Growth has been inconsistent, with periods of strong growth followed by periods of decline.
Future Projections: Future growth depends on the company's ability to execute its strategy, innovate, and capture market share.
Recent Initiatives: Focusing on pre-bill solutions, strategic partnerships, and technological advancements.
Summary
Streamline Health Solutions is a smaller player in the healthcare revenue cycle management market. The company's focus on pre-bill revenue integrity is a strength but is not resulting in major growth. It needs to scale more quickly and innovate further to compete effectively against larger companies with more resources. Its long-term success depends on its ability to execute its strategic plan and capture market share in a rapidly evolving industry.
Similar Companies
- OTEX
- CPSI
- ALLS
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Research Reports
- Industry Analysis
Disclaimers:
This analysis is for informational purposes only and should not be considered investment advice. Market share data is based on estimates and may vary. Financial data may not be current. Invest at your own risk.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Streamline Health Solutions Inc
Exchange NASDAQ | Headquaters Alpharetta, GA, United States | ||
IPO Launch date 1996-04-18 | CEO & Director Mr. Benjamin L. Stilwill | ||
Sector Healthcare | Industry Health Information Services | Full time employees 77 | Website https://www.streamlinehealth.net |
Full time employees 77 | Website https://www.streamlinehealth.net |
Streamline Health Solutions, Inc. offers health information technology solutions and associated services for hospitals and health systems in North America. The company offers RevID, a cloud-based automated revenue reconciliation software as a service (Saas) solution that delivers automated daily charge reconciliation, which identifies discrepancies between a provider's clinical and billing departments and ensures that every medical service is tracked, accounted for, and accurately billed and reduce revenue leakage; and eValuator, a coding analysis platform that delivers the capability of fully automated analysis on billing codes entered by a healthcare provider's coding team. It also provides Data Comparison Engine, a cloud-based SaaS system synchronization module that operates and automates the reconciliation of these systems to identify discrepancies or errors occurring between systems; CDI that provides an integrated on-premise or cloud-based software suite that enhances the productivity of CDI and Coding staff and enables the seamless sharing of patient data; and Financial Management Solutions, which offers financial staff across the healthcare enterprise with actionable and real-time financial data and key performance indicators to improve revenue realization. In addition, the company provides auditing and coding, software, and professional services. The company sells its solutions and services through direct sales force and reseller partnerships. Streamline Health Solutions, Inc. was incorporated in 1989 and is based in Alpharetta, Georgia.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.